Ketosis-Prone Diabetes—A New Subgroup of Patients with Atypical Type 1 and Type 2 Diabetes?
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
One objective for classification of a disease is the opportunity to study its epidemiology, etiology, and pathogenesis to provide various effective interventions for its prevention and treatment. The paper of Maldonado et al. (1) in this issue of JCEM reports on the classification of four groups of diabetic patients who presented with diabetic ketoacidosis (DKA). Of the two most common types of hyperglycemic crises, DKA most often occurs in type 1 diabetes (DM-1), and hyperglycemic hyperosmolar state most frequently arises in type 2 diabetes (DM-2). However, the occurrence of these acute metabolic emergencies is not specific to one type of diabetes or the other (2). Maldonado et al. (1) have carefully and meticulously studied a well-defined multiethnic group of patients with diabetes who presented with DKA. The study cohort was divided into four groups based on positive or negative β-cell insulin function (B+ or B−, respectively), as well as positive or negative autoimmune markers for DM-1 (A+ or A−, respectively). They also studied human leukocyte antigen class II genotype in these patients, profiled their demographic characteristics, and followed their response to insulin therapy on a longitudinal basis. Based on these criteria, they identified four groups: A+ B−, A− B−, A+ B+, and A− B+. This study demonstrates the heterogeneity associated with DKA and stimulates further discussion regarding the development of standardized nomenclature and a global database to establish a more accurate classification of ketosis-prone diabetes (KPD). According to the consensus report of the Expert Committee on Diagnosis and Classification of Diabetes Mellitus (3) and the World Health Organization (4), group A+ B− in the work of Maldonado et al. (1) would consist of type 1A diabetes mellitus, whereas A− B− would be considered as type 1 idiopathetic, because this group is nonobese with negative autoimmune markers and requires insulin for prevention of recurrence of DKA. Patients in this group, similar to the type 1A, also have low residual C-peptide but have a strong family history of DM-2, are frequently nonobese, and often are nonwhite with variable insulin requirement. Such patients have been reported in African countries as early as 1985 (5). This group is sometimes referred to as type 1.5 diabetes (6). The two groups with B+, however, are more heterogenous and share certain characteristics such as positive family history of DM-2, overweight or obese, mostly nonwhite, and often present in DKA as newly diagnosed DM. However, in this group, recurrence of DKA is rare after the initial event and often can initially be treated with diet or oral antidiabetic agents. These two groups have been described globally by various names, including “Flatbush diabetes,” “obese DKA,” “type 2 DM with DKA,” “newly onset with DKA,” “idiopathetic type 1 DM,” “atypical DM,” “type 3 KPD,” as well as “KPD B+.” Table 1 (courtesy of Dr. Mario Maldonado) summarizes the clinical characteristics and demographics of these patients as reported by various investigators (7–14). Of the two groups’ B+ cohorts, A− B+ most likely would consist of a heterogenous group of DM-2 patients with various degrees of insulin resistance and varying degrees of insulin secretory capacity. However, at the time of appearance of DKA, they have relatively lower C-peptide and increased counterregulatory hormones compared with hyperglycemic nonketosis patients (15). The last group, A+ B+, on the other hand poses the most challenging task as to the exact nomenclature for its classification or assignment of its etiopathological mechanism. Included in this category is a subclassification of individuals who had previously been labeled as latent autoimmune diabetes of adult (16–19). Maldonado et al. (1) designated 11 patients under the A+ B+ category and further subdivided them into two groups. Although the numbers in each subgroup are not large enough to make a definitive conclusion, the results are provocative enough that one may be tempted to propose certain hypotheses. Of the 11 patients in this category, six are positive for susceptibility gene DQB1*02, five of whom require insulin to prevent recurrence of DKA and have average glycosylated hemoglobin (HbA1c) of about 8.6%. All patients in the second subgroup of five lack DQB*02 genes; four require no insulin for future therapy, and their HbA1c average is about 6.5%. Most interesting in this A+ B+ group is the autoimmune profile of these patients, compared with the A+ B− (type 1A) patients (Table 2). Whereas in A+ B− group, whose HbA1c is greater than 10%, the major autoantibodies are IA-2 (61%) with 50% glutamic acid decarboxylase (GAD)65 and 17% combined GAD65 + IA-2, the A+ B+ patients exhibit 82% GAD65, only 18% IA-2, and no GAD65 + IA-2 antibodies. It therefore appears that type 1A patients who have higher frequency of IA-2 antibodies and more severe DKA than the group A+ B+ support the recent emerging concept that IA-2 p
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diabetes Antibody Standardization Program: first assay proficiency evaluation
Bingley, P. J., Bonifacio, E., Mueller, P. W., & Laboratories, P. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1128 · Cited by 362
Banerji, M. A., Chaiken, R. L., Huey, H., Tuomi, T., Norin, A. J., Mackay, I. R., Rowley, M. J., Zimmet, P. Z., & Lebovitz, H. E. (1994) · Diabetes · doi:10.2337/diab.43.6.741 · Cited by 266
Cited by
Hyperglycemic crises in adult patients with diabetes
Kitabchi, A. E., Umpierrez, G. E., Miles, J. M., & Fisher, J. N. (2009) · Diabetes Care · doi:10.2337/dc09-9032 · Cited by 2,062
Self-citationHyperglycemic Crises in Adult Patients With Diabetes
Kitabchi, A. E., Umpierrez, G. E., Murphy, M. B., & Kreisberg, R. A. (2006) · Diabetes Care · doi:10.2337/dc06-9916 · Cited by 512
Self-citationThe evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management
Nyenwe, E. A., & Kitabchi, A. E. (2016) · Metabolism · doi:10.1016/j.metabol.2015.12.007 · Cited by 309
Self-citationNarrative Review: Ketosis-Prone Type 2 Diabetes Mellitus
Umpierrez, G. E., Smiley, D., & Kitabchi, A. E. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-5-200603070-00011 · Cited by 299
“Obesity in persons with diabetic ketoacidosis from minority ethnic groups is more common than in white persons, in whom the rate of obesity is less than 20% (28, 29).”
BackgroundSelf-citationKitabchi, A. E., Umpierrez, G. E., Fisher, J. N., Murphy, M. B., & Stentz, F. B. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2577 · Cited by 210
Self-citation
Metadata
- Authors
- Kitabchi, A. E.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-11-01
- Volume
- 88
- Issue
- 11
- Pages
- 5087-5089
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1973261288
- Cited by
- 50
- References
- 2
- FWCI
- 1.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ketosis-Prone Diabetes—A New Subgroup of Patients with Atypical Type 1 and Type 2 Diabetes? https://app.cochat.ai/papers/10.1210/jc.2003-031656
- The paper
- Kitabchi, A. E. (2003). Ketosis-Prone Diabetes—A New Subgroup of Patients with Atypical Type 1 and Type 2 Diabetes? The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2003-031656
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.